Recognizing Eating Disorders in Routine Clinical Care (Jackie)
Curriculum:
Missed Opportunities in the Recognition of Eating Disorders
Missed Opportunities in the Recognition of Eating Disorders
Credits:
1 AMA PRA Category 1 Credit(s) ™
1 AMA PRA Category 1 Credit(s) ™
Launch Date:
April 07, 2015
April 07, 2015
Expiration Date:
The accreditation for this activity has expired.
The accreditation for this activity has expired.
Primary Audience:
Primary care (MD/DO/PA/NP) and OBGYN clinicians who have the greatest opportunity to suspect BED but may be the least prepared to recognize and effectively treat or refer; Psychiatrists treating depression and anxiety disorders who may miss the diagnosis unless they probe for it when evaluating their patients.
Relevant Terms:
Eating disorders; binge eating disorder; obesity and overweight; depression; anxiety; substance use disorders
Angela Guarda, MD
Angela Guarda, MD
Associate Professor of Psychiatry and Behavioral Sciences
The John Hopkins School of Medicine
Baltimore, MD
Bio
Angela Guarda is an associate professor at the Johns Hopkins University School of Medicine, directs the Eating Disorders Program. Her expertise is in treating patients with anorexia nervosa and bulimia, and she researches predictors of outcome in these patients as well as using neuroimaging to better understand eating disorders. Guarda received her medical degree in 1991 from the University of Maryland, and she has been at Johns Hopkins since her psychiatry residency in 1992.
Janelle Coughlin, PhD
Janelle Coughlin, PhD
Assistant Professor of Psychiatry and Behavioral Sciences
Department of Psychiatry
The Johns Hopkins School of Medicine
Baltimore, MD
Bio
Dr. Coughlin's research interests include eating disorders, binge eating behavior, and behavioral weight loss treatment. She is currently involved in an ongoing research project examining psychosocial predictors of treatment outcomes in inpatients with eating disorders and a clinical trial assessing binge eating in overweight and obese patients enrolled in a behavioral weight loss program. Additionally, she is involved in a neuroimaging study of bulimia nervosa and a study examining satiety signaling in anorexia nervosa.
Nicholas T. Bello, PhD
Nicholas T. Bello, PhD
Assistant Professor
Department of Animal Sciences
Rutgers University
New Brunswick, NJ
Bio
Dr. Nicholas Bello is an Assistant Professor at Rutgers, the State University of New Jersey. He completed his postdocotoral fellowship at the Department of Psychiatry and Behavioral Sciences at the Johns Hopkins University in Baltimore, Maryland.
| 1. | Recognize symptoms and comorbidities that suggest a differential diagnosis of BED | 2. | Identify accurate diagnostic criteria and appropriate screening tools for BED |
| 3. | Explain how to initiate a patient conversation about eating disorders | 4. | Describe how neurochemical effects of eating influence patterns in BED |
| 5. | Evaluate psychological, self-help, and pharmacologic BED treatment options |
| 1. | Recognize symptoms and comorbidities that suggest a differential diagnosis of BED |
| 2. | Identify accurate diagnostic criteria and appropriate screening tools for BED |
| 3. | Explain how to initiate a patient conversation about eating disorders |
| 4. | Describe how neurochemical effects of eating influence patterns in BED |
| 5. | Evaluate psychological, self-help, and pharmacologic BED treatment options |
Presented by the Johns Hopkins University School of Medicine
Supported by an educational grant from Shire Pharmaceuticals
ACCREDIATION STATEMENT
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION
The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Length of activity: 1 hour
Length of activity: 1 hour
METHOD OF PARTICIPATION
There are no fees for participating in this CME activity. To receive credit, participants must (1) read the learning objectives and disclosure statements, (2) complete the educational activity, and (3) complete the post-test and activity evaluation form, including the certificate information section
SUCCESSFUL COMPLETION
You must complete the post-test at the end of the activity with a passing grade of 70% or higher.
RELEASE DATE
Date of release: April 7, 2015
Expiration date: April 6, 2017
Expiration date: April 6, 2017
This activity is intended for Primary care (MD/DO/PA/NP), OBGYN, and Psychiatrists treating depression and/or anxiety disorders.
PREREQUISITES
There are no prerequisites.
Through a review of the current literature, including national and regional measures the following core learning gaps have been identified:
* Many clinicians are unfamiliar with BED and may not consider BED when assessing and diagnosing their patients.
* Clinician uncertainty about accurately diagnosing BED may limit effective treatment.
* Clinicians may not be versed in emerging data about the neurochemical effects of eating and their potential relationship to BED.
STATEMENT OF RESPONSIBILITY
The Johns Hopkins University School of Medicine takes responsibility for the content, quality and scientific integrity of this CME activity.
The Johns Hopkins University School of Medicine takes responsibility for the content, quality and scientific integrity of this CME activity.
DISCLAMER
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of The Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
INTERNET CME POLICY
The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protecting the privacy of its members and customers. Johns Hopkins University SOM CME maintains its Internet site as an information resource and service for physicians, other health professionals and the public.
Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet-based program. Your information will never be given to anyone outside of the Johns Hopkins University School of Medicine's CME program. CME collects only the information necessary to provide you with the services that you request.
MEDIUM
The Internet was selected as the instructional format to accommodate the learning preferences of a significant portion of the target audience.
COURSE VIEWING REQUIREMENTS
| Supported Browsers: Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8 Google Chrome 28.0+ for Windows, Mac OS, or Linux Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux Safari 6+ for Mac OSX 10.7 and above For video playback, install the latest version of Flash or Quicktime. | Supported Phones & Tablets: Android 4.0.3 and above iPhone/iPad with iOS 6.1 or above |
CONFIDENTIALITY DISCLAIMER FOR CME CONFERENCE ATTENDEES
I certify that I am attending a Johns Hopkins University School of Medicine CME activity for accredited training and/or educational purposes.
I understand that while I am attending in this capacity, I may be exposed to "protected health information," as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the "Privacy Regulations"). Protected health information is information about a person’s health or treatment that identifies the person.
I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential. I agree not to post or discuss this protected health information, including pictures and/or videos, on any social media site (e.g. Facebook, Twitter, etc), in any electronic messaging program or through any portable electronic device.
I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is: Johns Hopkins Privacy Officer, telephone: 410-735-6509, e-mail: HIPAA@jhmi.edu.
"The Office of Continuing Medical Education at the Johns Hopkins University School of Medicine, as provider of this activity, has relayed information with the CME attendees/participants and certifies that the visitor is attending for training, education and/or observation purposes only."
For CME Questions, please contact the CME Office at (410) 955-2959 or e-mail cmenet@jhmi.edu.
For CME Certificates, please call (410) 502-9634.
Johns Hopkins University School of Medicine Office of Continuing Medical Education Turner 20/720 Rutland Avenue Baltimore, Maryland 21205-2195
Reviewed & Approved by: General Counsel, Johns Hopkins Medicine (4/1/03) (Updated 4/09 and 3/14)
Full Disclosure Policy Affecting CME Activities
As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) to require signed disclosure of the existence of financial relationships with industry from any individual in a position to control the content of a CME activity sponsored by OCME. Members of the Planning Committee are required to disclose all relationships regardless of their relevance to the content of the activity. Faculty are required to disclose only those relationships that are relevant to their specific presentation. The following relationships have been reported for this activity:
Planner Disclosure
Janelle Coughlin, PhD
Dr. Coughlin has disclosed that she has worked as a consultant for Healthways, Inc and served as a Principal Investigator for Merck.
Faculty Disclosure
Nicholas Bello, MD
Dr. Bello has disclosed he has served as a consultant for Shire Pharmaceuticals.
ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT
Supported by an educational grant from Shire Pharmaceuticals.
To participate in additional CME activities presented by the Johns Hopkins University School of Medicine Continuing Medical Education Office, please visit www.hopkinscme.edu
Dr. Coughlin has disclosed that she has worked as a consultant for Healthways, Inc and served as a Principal Investigator for Merck.
No other planners have indicated that they have any financial interests or relationships with a commercial entity.
*Angela Guarda, MD
*Angela Guarda, MD
*Michael Clark, MD
Faculty Disclosure
Nicholas Bello, MD
Dr. Bello has disclosed he has served as a consultant for Shire Pharmaceuticals.
No other faculty members have indicated that they have any financial interests or relationships with a commercial entity whose products or services are relevant to the content of their presentations.
OFF-LABEL PRODUCT DISCUSSION
The faculty reports the activity will contain off-label discussion of selective serotonin reuptake inhibitors (SSRIs), fluoxetine (an SSRI), topiramate, and zonisamide.
ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT
Supported by an educational grant from Shire Pharmaceuticals.
To participate in additional CME activities presented by the Johns Hopkins University School of Medicine Continuing Medical Education Office, please visit www.hopkinscme.edu
© All rights reserved. The Johns Hopkins University School of Medicine
Presented by JHUSOM in collaboration win DKBmed.
